Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants

Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged public health around the world. Currently, there is an urgent need to explore antiviral therapeutic targets and effective clinical drugs. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jialing, Li, Chengcheng, Ye, Chunhong, Ruan, Zhihui, Liang, Yicong, Li, Yongkui, Wu, Jianguo, Luo, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802458/
https://www.ncbi.nlm.nih.gov/pubmed/35126885
http://dx.doi.org/10.1016/j.csbj.2022.01.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802458/
https://www.ncbi.nlm.nih.gov/pubmed/35126885
http://dx.doi.org/10.1016/j.csbj.2022.01.026

Ejemplares similares